α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer's Disease.
Accumulating evidence suggests that α7 nicotinic receptors (α7 nAChRs), a subtype of nAChRs, play a role in the pathophysiology of neuropsychiatric diseases, including schizophrenia and Alzheimer's disease (AD). A number of psychopharmacological and genetic studies shown that α7 nAChRs play an important role in the deficits of P50 auditory evoked potential in patients with schizophrenia, and that (α nAChR agonists would be potential therapeutic drugs for cognitive impairments associated with P50 deficits in schizophrenia. Furthermore, some studies have demonstrated that α7 nAChRs might play a key role in the amyloid-β (Aβ)-mediated pathology of AD, and that α7 nAChR agonists would be potential therapeutic drugs for Aβ deposition in the brains of patients with AD. Interestingly, the altered expression of α7 nAChRs in the postmortem brain tissues from patients with schizophrenia and AD has been reported. Based on all these findings, selective α7 nAChR agonists can be considered potential therapeutic drugs for cognitive impairments in both schizophrenia and AD. In this article, we review the recent research into the role of α7 nAChRs in the pathophysiology of these diseases and into the potential use of novel α7 nAChR agonists as therapeutic drugs.
Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan.
Jun
J
Toyohara
Kenji
K
Hashimoto
Schizophr Bull. 1996;22(3):431-45
8873294
PLoS One. 2008 Sep 18;3(9):e3231
18800169
J Pharmacol Exp Ther. 2001 Aug;298(2):395-402
11454899
Arch Gen Psychiatry. 2002 Dec;59(12):1085-96
12470124
Biochem Pharmacol. 2009 Oct 1;78(7):880-8
19615981
Trends Pharmacol Sci. 2004 Jun;25(6):317-24
15165747
Am J Psychiatry. 2001 Aug;158(8):1319-21
11481170
Nihon Shinkei Seishin Yakurigaku Zasshi. 2002 Apr;22(2):49-53
12050852
Brain Res Brain Res Rev. 2000 Sep;33(2-3):275-307
11011070
J Neurochem. 1999 Oct;73(4):1590-7
10501205
Psychopharmacology (Berl). 2008 Apr;197(3):499-508
18265960
Genes Brain Behav. 2006;5 Suppl 1:14-22
16417613
J Pharmacol Exp Ther. 2000 Sep;294(3):1112-9
10945867
Neuropsychopharmacology. 2007 Jan;32(1):17-34
16936709
Bioorg Med Chem Lett. 2005 Nov 1;15(21):4727-30
16165358
J Neurosci. 2007 Sep 26;27(39):10578-87
17898229
Rev Physiol Biochem Pharmacol. 2003;147:1-46
12783266
J Biol Chem. 2000 Feb 25;275(8):5626-32
10681545
Psychopharmacology (Berl). 2000 Jun;150(2):233-6
10907678
Prog Neurobiol. 2000 May;61(1):75-111
10759066
Neuroreport. 1999 Jun 3;10(8):1779-82
10501574
Curr Opin Pharmacol. 2004 Feb;4(1):36-46
15018837
Curr Pharm Des. 2006;12(6):677-84
16472157
J Chem Neuroanat. 2001 Jul;22(1-2):115-26
11470559
Mol Neurobiol. 1999 Aug;20(1):1-16
10595869
Neurosci Lett. 2007 May 17;418(2):154-8
17379406
J Pharmacol Exp Ther. 2000 Feb;292(2):461-7
10640281
Neuropsychopharmacology. 2004 Aug;29(8):1522-6
15100704
Front Biosci. 2007 May 01;12:4755-72
17485411
Biol Psychiatry. 2001 Feb 1;49(3):175-84
11230868
Mol Pharmacol. 1982 Nov;22(3):554-64
7155123
Arch Neurol. 2007 Dec;64(12):1771-6
18071042
J Neurosci. 2001 Jan 1;21(1):RC120
11150356
Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17;33(2):269-75
19110025
J Neurosci. 2002 May 1;22(9):3338-41
11978809
Neuropharmacology. 2009 May-Jun;56(6-7):1001-9
19233218
Neuroscience. 2002;110(2):199-211
11958863
J Neurobiol. 2003 Apr;55(1):25-30
12605456
Psychopharmacology (Berl). 2003 Sep;169(3-4):257-97
12601500
J Pharmacol Exp Ther. 1998 Dec;287(3):918-25
9864273
Schizophr Res. 2005 Jul 1;76(1):67-72
15927799
Am J Med Genet. 1998 Jul 10;81(4):308-12
9674976
J Neurobiol. 2002 Dec;53(4):512-23
12436416
Bioorg Med Chem Lett. 2004 Apr 19;14(8):1849-53
15050614
J Pharmacol Exp Ther. 2000 Nov;295(2):438-46
11046074
Brain Res. 2008 Aug 28;1227:240-7
18619425
J Pharmacol Exp Ther. 2004 Apr;309(1):16-27
14722323
FASEB J. 2003 Oct;17(13):1948-50
12897067
Behav Brain Res. 2000 Aug;113(1-2):183-92
10942044
J Med Chem. 2005 Apr 7;48(7):2678-86
15801858
J Pharmacol Exp Ther. 2009 May;329(2):459-68
19223665
Science. 1991 Oct 18;254(5030):432-7
1718042
Curr Opin Neurobiol. 1997 Oct;7(5):674-82
9384554
J Neurosci. 2009 Sep 2;29(35):10961-73
19726654
Curr Drug Targets CNS Neurol Disord. 2004 Apr;3(2):123-30
15078187
J Med Chem. 2005 Feb 24;48(4):905-8
15715459
J Neurosci Res. 2007 Jun;85(8):1810-8
17455307
Bioorg Med Chem Lett. 2004 Jul 16;14(14):3781-4
15203161
Curr Med Chem. 2000 Aug;7(8):749-800
10828287
Curr Top Med Chem. 2010;10(15):1544-57
20583992
J Neurosci. 1993 May;13(5):1965-75
8478687
Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):587-92
9012828
Mol Pharmacol. 1992 Jan;41(1):31-7
1732720
J Pharmacol Exp Ther. 2005 Mar;312(3):1213-22
15523001
Neuron. 2004 May 27;42(4):522-4
15157413
Psychopharmacology (Berl). 2004 Jun;174(1):54-64
15205879
Brain Res. 1981 Jul 20;216(2):449-54
7248786
Neuropsychopharmacology. 2003 Mar;28(3):542-51
12629535
Am J Psychiatry. 1993 Dec;150(12):1856-61
8238642
Bioorg Med Chem Lett. 2001 Feb 12;11(3):319-21
11212100
J Neurosci. 2009 Jul 8;29(27):8805-15
19587288
Biol Psychiatry. 1995 Jul 1;38(1):22-33
7548469
Am J Geriatr Pharmacother. 2009 Jun;7(3):167-85
19616185
J Med Chem. 2000 Nov 2;43(22):4045-50
11063601
CNS Neurosci Ther. 2008 Spring;14(1):65-82
18482100
Psychopharmacology (Berl). 2002 Jul;162(2):102-18
12110988
Bioorg Med Chem Lett. 2009 Mar 1;19(5):1287-91
19208472
J Chem Neuroanat. 2000 Dec;20(3-4):299-306
11207427
Schizophr Bull. 1987;13(4):669-78
2894074
Biol Psychiatry. 1992 Oct 1;32(7):607-16
1450287
Neuropsychopharmacology. 2009 Jun;34(7):1753-63
19158670
Trends Pharmacol Sci. 2000 Jun;21(6):211-7
10838608
Nature. 1996 Oct 24;383(6602):713-6
8878480
J Med Chem. 2006 Jul 13;49(14):4374-83
16821797
Psychopharmacology (Berl). 2005 Nov;183(1):13-9
16136299
J Neurochem. 2000 Jan;74(1):237-43
10617125
Trends Pharmacol Sci. 2002 Mar;23(3):130-6
11879680
Behav Brain Res. 2000 Aug;113(1-2):97-103
10942036
Br J Pharmacol. 2008 Mar;153(5):1054-61
18157163
Mol Pharmacol. 2004 Jan;65(1):56-67
14722237
Ann Nucl Med. 2009 May;23(3):301-9
19337782
J Physiol Paris. 1998 Jun-Aug;92(3-4):309-16
9789829
J Neurosci Res. 1990 Nov;27(3):349-59
2097379
Invert Neurosci. 1997 Sep-Dec;3(2-3):251-9
9783447
Neurosci Lett. 1996 Aug 9;213(3):201-4
8873149
Pharmacol Ther. 2001 Nov-Dec;92(2-3):89-108
11916531
Alzheimer Dis Assoc Disord. 1987;1(3):128-55
3331115
Behav Pharmacol. 1999 Nov;10(6-7):675-80
10780509
Br J Psychiatry. 2007 Nov;191:402-7
17978319
J Med Chem. 1997 Dec 19;40(26):4169-94
9435889
Trends Neurosci. 1999 Dec;22(12):555-61
10542436
J Med Chem. 2009 Jul 23;52(14):4126-41
19552432
J Neurochem. 1999 Oct;73(4):1635-40
10501210
Biochem Pharmacol. 2007 Oct 15;74(8):1192-201
17714692
Arch Gen Psychiatry. 1990 Feb;47(2):181-8
2405807
Neurosci Lett. 2007 Apr 6;416(1):61-5
17314009
Neuropsychopharmacology. 2000 May;22(5):451-65
10731620
Harv Rev Psychiatry. 1994 Nov-Dec;2(4):179-92
9384901
Brain Res Mol Brain Res. 2000 Mar 29;76(2):385-8
10762715
Bioorg Med Chem. 2006 Dec 15;14(24):8219-48
17011782
Bioorg Med Chem. 2009 Jul 15;17(14):5247-58
19515567
Genomics. 1998 Sep 1;52(2):173-85
9782083
Biochem Pharmacol. 2009 Oct 1;78(7):803-12
19482012
Prog Brain Res. 2004;145:235-51
14650919
Bioorg Med Chem Lett. 2008 Jun 15;18(12):3611-5
18490160
Neuropharmacology. 2008 Mar;54(4):676-85
18187166
J Neurophysiol. 2003 Apr;89(4):1797-806
12611953
Am J Med Genet. 1998 Jul 10;81(4):282-9
9674972
Curr Med Res Opin. 2003;19(3):169-77
12814128
J Neurochem. 2000 Sep;75(3):1155-61
10936198
Arch Gen Psychiatry. 2006 Jun;63(6):630-8
16754836
Am J Psychiatry. 2006 Oct;163(10):1832-4
17012698
Acta Physiol Scand. 1988 Jan;132(1):1-14
3223299
Prog Neurobiol. 1997 Oct;53(2):199-237
9364611
Biol Psychiatry. 2008 Jan 1;63(1):92-7
17601496
Brain Res. 2009 Apr 10;1265:65-74
19230830
Neuropsychopharmacology. 2007 Jan;32(1):1-16
17019409
Psychopharmacology (Berl). 2008 Mar;196(4):555-64
18034231
Eur J Pharmacol. 2006 Dec 28;553(1-3):191-5
17094961
J Neurobiol. 2002 Dec;53(4):633-40
12436426
Eur J Neurosci. 1997 Dec;9(12):2734-42
9517478
Am J Psychiatry. 2008 Aug;165(8):1040-7
18381905
J Med Chem. 2006 Jul 13;49(14):4425-36
16821801
Brain Res Mol Brain Res. 1999 Mar 20;66(1-2):94-103
10095081
Curr Drug Targets CNS Neurol Disord. 2002 Apr;1(2):149-62
12769624
Pharmacol Biochem Behav. 1997 May-Jun;57(1-2):231-41
9164577
Bioorg Med Chem Lett. 2005 Apr 15;15(8):2073-7
15808471
Neuropharmacology. 2009 Jan;56(1):254-63
18793655
Mol Pharmacol. 1995 Jan;47(1):164-71
7838125
Behav Brain Res. 2000 Aug;113(1-2):169-81
10942043
J Pharmacol Exp Ther. 2007 May;321(2):716-25
17308038
Annu Rev Pharmacol Toxicol. 1996;36:597-613
8725403
Arch Neurol. 2009 May;66(5):646-51
19433665
Neuropharmacology. 2007 Jul;53(1):134-44
17544457
Schizophr Bull. 1998;24(2):189-202
9613620
J Pharmacol Exp Ther. 2008 Jan;324(1):179-87
17959745
J Biol Chem. 2003 Aug 22;278(34):31547-53
12801934
Neuromolecular Med. 2008;10(4):377-84
18696274
Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4734-9
11274373
Eur J Neurosci. 1999 Jul;11(7):2551-65
10383644